- Investor Group Braveheart acquired a 33% stake in Pharm2Farm, a spin out from Nottingham Trent University.

Nottingham Trent University (NTU) and Pharm2Farm (P2F) had developed and patented a process to increase the bioavailability of trace minerals in plant feeds.

Their patented process uses nanotechnology to dramatically improve trace element take-up in both flower and crop farming. P2F produces and sell these products through an exclusive licence to this technology from NTU.

'The Board of Braveheart believes there is a substantial market opportunity for this technology and is in negotiations to take the Group's shareholding in P2F to 54% by way of a working capital investment,' the commpany said.

At 8:31am: [LON:BRH] Braveheart Investment Group PLC share price was +0.75p at 10.5p

Story provided by